These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8041270)

  • 21. Redox conversions of methemoglobin during redox cycling of quinones and aromatic nitrocompounds.
    CĂ©nas N; Ollinger K
    Arch Biochem Biophys; 1994 Nov; 315(1):170-6. PubMed ID: 7979395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Limiting factors of methemoglobin formation through phenylhydroxylamine in the erythrocytes of cattle, sheep and swine].
    Wagner J; Burger A
    Naunyn Schmiedebergs Arch Pharmakol Exp Pathol; 1966; 254(2):138-51. PubMed ID: 4383121
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of ferrylhemoglobin and methemoglobin on the human erythrocyte membrane.
    Sztiller M; Puchala M; Kowalczyk A; Bartosz G
    Redox Rep; 2006; 11(6):263-71. PubMed ID: 17207308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methemoglobin formation and glutathione disappearance in cord blood red cells exposed to acetylphenylhydrazine.
    Etukudo MH; Ramachandran M; Iyer GY
    Clin Chim Acta; 1984 Apr; 138(2):135-9. PubMed ID: 6723057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Limiting factors of methemoglobin formation through phenylhydroxylamine in hemolysates of different animal species].
    Uehleke H; Burger A; Wagner J
    Naunyn Schmiedebergs Arch Pharmakol Exp Pathol; 1966; 254(2):152-8. PubMed ID: 4383434
    [No Abstract]   [Full Text] [Related]  

  • 26. Procabazine induced oxidative haemolysis: relationship in vivo red cell survival.
    Sponzo RW; Arseneau JC; Canellos GP
    Br J Haematol; 1974 Aug; 27(4):587-95. PubMed ID: 4417500
    [No Abstract]   [Full Text] [Related]  

  • 27. An essential requirement for ferrous-haemoglobin in the hydrogen peroxide stimulated oxidation of red blood cell membrane lipids.
    Clemens MR; Einsele H; Remmer H; Waller HD
    Biochem Pharmacol; 1985 Apr; 34(8):1339-41. PubMed ID: 3994750
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of hydrogen peroxide removal reaction by hemoglobin in the presence of reduced pyridine nucleotides.
    Masuoka N; Kodama H; Abe T; Wang DH; Nakano T
    Biochim Biophys Acta; 2003 Jan; 1637(1):46-54. PubMed ID: 12527406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimalarial quinones: redox potential dependence of methemoglobin formation and heme release in erythrocytes.
    Lopez-Shirley K; Zhang F; Gosser D; Scott M; Meshnick SR
    J Lab Clin Med; 1994 Jan; 123(1):126-30. PubMed ID: 8288952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the mechanism of methemoglobin formation induced by aminoazo compounds.
    Lin JK; Wu YH
    Biochem Pharmacol; 1973 Aug; 22(15):1883-91. PubMed ID: 4722458
    [No Abstract]   [Full Text] [Related]  

  • 31. Iron-mediated oxidative stress in erythrocytes.
    Rice-Evans C; Baysal E
    Biochem J; 1987 May; 244(1):191-6. PubMed ID: 3663112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutathione. 3. Biological aspects of the azoester procedure for oxidation within the normal human erythrocyte.
    Kosower NS; Song KR; Kosower EM
    Biochim Biophys Acta; 1969 Oct; 192(1):15-22. PubMed ID: 5347968
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between red blood cell uptake and methemoglobin production by nitrobenzene and dinitrobenzene in vitro.
    Goldstein RS; Rickert DE
    Life Sci; 1985 Jan; 36(2):121-5. PubMed ID: 3965845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic and morphologic effects of the antimicrobial agent nitrofurantoin on human erythrocytes in vitro.
    Dershwitz M; Ts'ao CH; Novak RF
    Biochem Pharmacol; 1985 Jun; 34(11):1963-70. PubMed ID: 4004912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Mar; 45(5):1027-33. PubMed ID: 8461032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro oxidation of mercury by the blood.
    Hursh JB; Sichak SP; Clarkson TW
    Pharmacol Toxicol; 1988 Oct; 63(4):266-73. PubMed ID: 3194348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red cell membrane response to hydrogen peroxide-sensitivity in hereditary xerocytosis and in other abnormal red cells.
    Snyder LM; Sauberman N; Condara H; Dolan J; Jacobs J; Szymanski I; Fortier NL
    Br J Haematol; 1981 Jul; 48(3):435-44. PubMed ID: 7259992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopreservation of red blood cells--the struggle with hemoglobin oxidation.
    Kanias T; Acker JP
    FEBS J; 2010 Jan; 277(2):343-56. PubMed ID: 19968714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interdependence of hemoglobin, catalase and the hexose monophosphate shunt in red blood cells exposed to oxidative agents.
    Sullivan SG; Stern A
    Biochem Pharmacol; 1980 Sep; 29(17):2351-9. PubMed ID: 6252900
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxia-reoxygenation.
    McLeod LL; Alayash AI
    Am J Physiol; 1999 Jul; 277(1):H92-9. PubMed ID: 10409186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.